Literature DB >> 17618417

Adrenal response in patients with septic shock of abdominal origin: relationship to survival.

Florence C Riché1, Carole M Boutron, Patrice Valleur, Christine Berton, Marie-Josèphe Laisné, Jean-Marie Launay, Philippe Chappuis, Jacqueline Peynet, Eric Vicaut, Didier Payen, Bernard P Cholley.   

Abstract

OBJECTIVE: To evaluate the prognostic value of adrenocortical response to corticotropin in septic shock patients operated on exclusively for an intra-abdominal source of infection. DESIGN AND
SETTING: Prospective, observational, single-center study in a surgical intensive care unit of a university hospital PATIENTS: 118 consecutive septic shock patients undergoing laparotomy or drainage for intra-abdominal infection. MEASUREMENTS AND
RESULTS: Baseline cortisol (t (0)) and cortisol response to corticotropin test (Delta) were measured during the first 24 h following onset of shock. The relationship between adrenal function test results and survival was analyzed as well as the effect of etomidate anesthesia. Cortisol plasma level at t (0) was higher in nonsurvivors than in survivors (33 +/- 23 vs. 25 +/- 14 microg/dl), but the response to corticotropin test did not differ between these two subgroups. ROC analysis showed threshold values for t (0) (32 microg/dl) and Delta (8 microg/dl) that best discriminated survivors from nonsurvivors in our population. We observed no difference in survival at the end of hospital stay using log rank test when patients were separated according to t (0), Delta, or both. In addition, adrenal function tests and survival did not differ in patients who received etomidate anesthesia (n = 69) during the surgical treatment of their abdominal sepsis.
CONCLUSIONS: In this cohort of patients with abdominal septic shock baseline cortisol level and the response to corticotropin test did not discriminate survivors from nonsurvivors. No deleterious impact of etomidate anesthesia on adrenal function tests and survival was observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618417     DOI: 10.1007/s00134-007-0770-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  37 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Etomidate and intensive care physicians.

Authors:  Roxanna Bloomfield; David Noble
Journal:  Intensive Care Med       Date:  2005-08-11       Impact factor: 17.440

3.  Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery.

Authors:  Y Naito; J Fukata; S Tamai; N Seo; Y Nakai; K Mori; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1991-07       Impact factor: 5.958

Review 4.  Corticosteroid therapy in severe illness.

Authors:  S W Lamberts; H A Bruining; F H de Jong
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

5.  Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.

Authors:  A Absalom; D Pledger; A Kong
Journal:  Anaesthesia       Date:  1999-09       Impact factor: 6.955

6.  Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.

Authors:  G Zanetti; D Heumann; J Gérain; J Kohler; P Abbet; C Barras; R Lucas; M P Glauser; J D Baumgartner
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

7.  Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock.

Authors:  J L Moran; M J Chapman; M S O'Fathartaigh; A R Peisach; P R Pannall; P Leppard
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

8.  Hormonal responses to graded surgical stress.

Authors:  B Chernow; H R Alexander; R C Smallridge; W R Thompson; D Cook; D Beardsley; M P Fink; C R Lake; J R Fletcher
Journal:  Arch Intern Med       Date:  1987-07

9.  Adrenocortical function during septic shock.

Authors:  G Bouachour; P Tirot; J P Gouello; E Mathieu; J F Vincent; P Alquier
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

10.  Prediction of outcome in intensive care patients using endocrine parameters.

Authors:  P M Rothwell; P G Lawler
Journal:  Crit Care Med       Date:  1995-01       Impact factor: 7.598

View more
  11 in total

1.  Is etomidate really that bad in septic patients?

Authors:  Fabio Moreira Andrade
Journal:  Intensive Care Med       Date:  2010-04-20       Impact factor: 17.440

2.  Initial observations regarding free cortisol quantification logistics among critically ill children.

Authors:  Jerry J Zimmerman; Ruth M Barker; Rhona Jack
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

Review 3.  The effect of etomidate on adrenal function in critical illness: a systematic review.

Authors:  Stewart G Albert; Srividya Ariyan; Ayesha Rather
Journal:  Intensive Care Med       Date:  2011-03-04       Impact factor: 17.440

4.  Proven infection-related sepsis induces a differential stress response early after ICU admission.

Authors:  Olivier Lesur; Jean-Francois Roussy; Frederic Chagnon; Nicole Gallo-Payet; Robert Dumaine; Philippe Sarret; Ahmed Chraibi; Lucie Chouinard; Bruno Hogue
Journal:  Crit Care       Date:  2010-07-09       Impact factor: 9.097

5.  Etomidate, adrenal function, and mortality in critically ill patients.

Authors:  Jacob E Sunshine; Steven Deem; Noel S Weiss; N David Yanez; Stephen Daniel; Katherine Keech; Marcia Brown; Miriam M Treggiari
Journal:  Respir Care       Date:  2013-04       Impact factor: 2.258

6.  Etomidate use and postoperative outcomes among cardiac surgery patients.

Authors:  Chad E Wagner; Julian S Bick; Daniel Johnson; Rashid Ahmad; Xue Han; Jesse M Ehrenfeld; Jonathan S Schildcrout; Mias Pretorius
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

7.  The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.

Authors:  Brian H Cuthbertson; Charles L Sprung; Djillali Annane; Sylvie Chevret; Mark Garfield; Serge Goodman; Pierre-Francois Laterre; Jean Louis Vincent; Klaus Freivogel; Konrad Reinhart; Mervyn Singer; Didier Payen; Yoram G Weiss
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

8.  Etomidate and mortality in cirrhotic patients with septic shock.

Authors:  Antoine J Cherfan; Hani M Tamim; Abdulrahman AlJumah; Asgar H Rishu; Abdulmajeed Al-Abdulkareem; Bandar A Al Knawy; Ali Hajeer; Waleed Tamimi; Riette Brits; Yaseen M Arabi
Journal:  BMC Clin Pharmacol       Date:  2011-12-30

9.  Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis.

Authors:  Boris Jung; Noemie Clavieras; Stephanie Nougaret; Nicolas Molinari; Antoine Roquilly; Moussa Cisse; Julie Carr; Gerald Chanques; Karim Asehnoune; Samir Jaber
Journal:  Crit Care       Date:  2012-11-21       Impact factor: 9.097

Review 10.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.